Raise up your asparagus spear and fight!  Diabetes UK is funding research into foods such as garlic, chicory, asparagus and artichokes, according to a report in Telegraph.  These foods, known as fermentable carbohydrates, are thought to activate the release of gut hormones that reduce appetite.  It is believed such fermentable...

A new study published in the Journal of the American Medical Association suggests that nearly 30 percent of U.S. diabetics over the age of 40 may have a diabetes-related eye disorder, with 4 percent of this population affected severely enough that their vision is threatened. The researchers found that men had a significantly higher...

PositiveID Corporation announced today that it has filed a provisional patent application with the U.S. Patent and Trademark Office for an insulin pen tracking and recording device. The Insulin Tracker, a microprocessor-controlled device that slides onto standard insulin pens, enables diabetes patients to automatically track and record...

Improved standards of living and hygiene may be contributing to the rising rate of type 1 diabetes. Researchers from the Washington State Department of Health trying to explain the continuous rise in incidents of type 1 diabetes studied records of children younger than 19 years hospitalized for type 1 diabetes in Washington State. The...

Researchers led by Columbia University Medical Center have discovered that the skeleton plays an important role in regulating blood sugar and have further illuminated how bone controls this process. The finding, published in Cell, is important because it may lead to more targeted drugs for type 2 diabetes. Led by Gerard Karsenty,...

MannKind Corporation announced that it has submitted, and the U.S. Food and Drug Administration (FDA) has accepted, MannKind’s resubmission of its New Drug Application (NDA) for AFREZZA(TM) (insulin human [rDNA origin]) and classified it as a Class 2 resubmission. With the Class 2 designation, the FDA...

Pfizer Inc. announced, at the request of the U.S. Food and Drug Administration (FDA), the suspension of the chronic low back pain and painful diabetic peripheral neuropathy studies in the clinical program for the investigational compound tanezumab. Investigation of the compound continues in some areas of high unmet medical need, including...

According to a new study from the University of Montreal (Canada) and the Université de Yaoundé (Cameroun) cashew seed extract shows promise as an effective anti-diabetic, EurekAlet reports. Published in the journal Molecular Nutrition & Food Research, the investigation analyzed the reputed health benefits of cashew tree...

Biodel Inc. reported results of preclinical tests which demonstrated the potential of the company’s glucose-regulated or “smart” basal insulin product candidate, BIOD620, to release insulin proportionally in response to changing glucose conditions. In an oral presentation today at the 37th Annual Meeting and Exposition...

University of Florida researchers have found that the variety of bacteria in a child’s digestive tract is strongly linked to whether that child develops type 1 diabetes. The connection could eventually give doctors an early test for the condition and a new way to treat the disease that afflicts more than 3 million Americans. The...